Cyclo Therapeutics (CYTH) Institutional Ownership $0.71 +0.03 (+4.42%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cyclo Therapeutics (NASDAQ:CYTH)CurrentInstitutional OwnershipPercentage68.55%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$939.26KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$46.41K Get CYTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Cyclo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CYTH Institutional Buying and Selling by Quarter Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Cyclo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/10/2024 EPIQ Capital Group LLC817,270$1.04M0.4%-4.3%2.856% 2/15/2024 Founders Fund V Management LLC480,708$764K80.8%N/A2.115% 2/15/2024 Founders Fund VI Management LLC110,023$175K1.4%N/A0.484% 11/9/2021BlackRock Inc.13,134$88K0.0%+21.1%0.204% 8/16/2021 State Street Corp44,700$457K0.0%N/A0.703% 8/13/2021 Geode Capital Management LLC42,577$435K0.0%+133.2%0.670% 8/13/2021 Vanguard Group Inc.151,540$1.55M0.0%+350.4%2.383% 5/12/2021 Geode Capital Management LLC18,257$149K0.0%N/A0.287% 3/26/2021 Susquehanna International Group LLP15,656$68K0.0%N/A0.249% 2/17/2021 Jane Street Group LLC27,892$121K0.0%N/A1.641% 2/17/2021 Worth Venture Partners LLC88,690$386K0.3%N/A5.217% 2/16/2021 Armistice Capital LLC100,000$435K0.0%N/A5.882% (Data available from 1/1/2016 forward) CYTH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CYTH shares? During the previous two years, the following institutional investors and hedge funds held shares of Cyclo Therapeutics shares: EPIQ Capital Group LLC ($1.04M), and Founders Fund V Management LLC ($764K), Founders Fund VI Management LLC ($175K).Learn more on CYTH's institutional investors. What percentage of Cyclo Therapeutics stock is owned by institutional investors? 68.55% of Cyclo Therapeutics stock is owned by institutional investors. Learn more on CYTH's institutional investor holdings. Which institutional investors have been buying Cyclo Therapeutics stock? The following institutional investors have purchased Cyclo Therapeutics stock in the last 24 months: Founders Fund V Management LLC ($480.71K), and Founders Fund VI Management LLC ($110.02K). How much institutional buying is happening at Cyclo Therapeutics? Institutional investors have bought a total of 590,731 shares in the last 24 months. This purchase volume represents approximately $939.26K in transactions. Which Cyclo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cyclo Therapeutics stock in the last 24 months: EPIQ Capital Group LLC ($36.55K). How much institutional selling is happening at Cyclo Therapeutics? Institutional investors have sold a total of 36,545 shares in the last 24 months. This volume of shares sold represents approximately $46.41K in transactions. Related Companies IKNA Major Shareholders QNCX Major Shareholders CLSD Major Shareholders CMRX Major Shareholders FBLG Major Shareholders IMAB Major Shareholders AVTE Major Shareholders EPIX Major Shareholders PDSB Major Shareholders HOWL Major Shareholders This page (NASDAQ:CYTH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
